The cancer driver signatures for SETDB1, YEATS4, NSD3, and BRD4 in TCGA datasets suggests that these genes are important cancer therapeutic targets and potential patient tailoring markers for epigenetics drug discovery efforts. The gene discussed is NSD3; the disease is cancer.